Description: Health Sciences Acquisitions Corporation 2 is a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. Health Sciences Acquisitions Corporation 2 anticipates targeting companies domiciled in North America or Europe that are developing assets in the biopharma and medical technology sectors, which aligns with our management team's experience in healthcare investing and drug development.
40 10th Avenue
New York,
NY
10014
United States
Phone:
646 597 6980
Officers
| Name | Title |
|---|---|
| Dr. Roderick Tze Ian Wong M.D. | Pres, CEO & Chairman |
| Dr. Naveen Yalamanchi M.D. | Exec. VP, CFO & Director |
| Ms. Alice Lee J.D. | VP of Operations, Sec. & Treasurer |
| Ms. Stephanie A. Sirota | VP of Corp. Strategy & Corp. Communications |
Exchange: NASDAQ
Country: US
Currency: US Dollar ($)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 1.8126 |
| Price-to-Sales TTM: | 0 |
| IPO Date: | 2020-08-04 |
| Fiscal Year End: | December |
| Full Time Employees: | 0 |